NSE:GLAND

Gland Pharma Limited · NSE · Healthcare · INR · FY for 2026

Figures on this page computed 2026-11-08 13:39 UTC

Last close

n/aINR

Market data

50.8xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
INR
- computed
- Computed from the filing for 2026
11.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
16.0%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
11.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.03Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.6%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
INR
- computed

Price is the furthest below its sector's middle: 0.17 against 0.36 on the market's range.

All from 100

lens 2 of 9

Sales

435

2017-03-31 to 2026-03-31100 at the start435

Sales: 100.00 on 2017-03-31 to 434.75 on 2026-03-31, up 335%.

Profit

248

2017-03-31 to 2026-03-31100 at the start248

Profit: 100.00 on 2017-03-31 to 248.31 on 2026-03-31, up 148%.

Shares in issue

106

2017-03-31 to 2026-03-31100 at the start106

Shares in issue: 100.00 on 2017-03-31 to 106.46 on 2026-03-31, up 6%.

Sales is at 435, Profit is at 248, Shares in issue is at 106, against 100 in 2017.

Sales is at 435, Profit is at 248, Shares in issue is at 106, against 100 in 2017.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

Sales, where the first year is 100435
Source
computed
Statement
income
Fiscal year
2026
Reported in
INR
Profit, where the first year is 100248
Source
computed
Statement
income
Fiscal year
2026
Reported in
INR
Shares in issue, where the first year is 100107
Source
computed
Statement
income
Fiscal year
2026
Reported in
INR